View
103
Download
0
Category
Preview:
DESCRIPTION
GHME 2013 Conference Session: New directions in cost-effectiveness analysis Date: June 16 2013 Presenter: Dean Jamison Institute: Center for Disease Dynamics, Economics & Policy University of Washington Department of Global Health
Citation preview
www.dcp-3.orginfo@dcp-3.org
Including Financial Protection and Equity in Health CEAs
Dean T. JamisonUniversity of Washington, Department of Global Health
Global Health Metrics and Evaluation ConferenceJune 16, 2013
104/10/2023
04/10/2023
Plan for this Talk
• Conceptual background
• Public finance of TB treatment of India
2
04/10/2023
Outcomes of a Policy
3
• Health gains (burden of disease averted)
• Financial protection benefits (“insurance” to households from medical impoverishment)
• Income consequences for households
• Distributional consequences (across income groups, ethnic subgroups or between males and female)
04/10/2023
Evaluation of Policy:Extended Cost-Effectiveness
Analysis (ECEA)
4
• Evaluation of interventions and platforms (CEA)(e.g. DOTS as an intervention surgical capacity at a district hospital as a
platform)
• Evaluation of Policies
04/10/2023 5
Policies
• Taxes and subsidies(e.g. universal public finance; tobacco taxes)
• Laws and regulation• Investment in capacity• Information and education
04/10/2023 6
Financial Risk Protection 1
• Enthoven (1987) stressed importance of FRP as a health system objective.
• Metrics include:• Incidence of impoverishment, excessive spending,
forced borrowing and forced asset sales (Wagstaff reviews results)
• Money-metric value of insurance
04/10/2023
Financial Risk Protection (2) Insurance
7
• Risk aversionIndividuals value protection from the risk of uncertain adverse events
y = individual incomer = coefficient of relative risk aversion
• Approach consistent with recent workMcClellan & Skinner. The incidence of Medicare.
Journal of Public Economics 2006 Smith. Incorporating financial protection into the economic evaluation of health technologies. Health Economics 2012
04/10/2023 8
Financial Risk Protection (3)
• Money-metric value of insurance providedGamble with:- disease occurs at incidence p (depending on income)
- has treatment cost c
• For 1 individual, money-metric value of insurance = expected value - certainty equivalent of gamble
04/10/2023
ECEA Structure
9
Policy Instrument
Health gains
(e.g. TB deaths averted)
Household expenditures
(e.g. TB-related costs
averted)
“Insurance” benefits(e.g. financial
protection from TB-related costs)
Poorest 2nd Poorest Middle 2nd Richest Richest
04/10/2023
Universal public finance of TB treatment in India
Work undertaken with Stéphane Verguet and Ramanan Laxminarayan
10
04/10/2023
Tuberculosis in India
11
• TB epidemiologyAnnual incidence of 100 per 100,000 (sputum smear-positives) (WHO
2012)
4 times higher incidence among the poor (Muniyandi et al. 2007)
Case fatality rate of untreated case 0.32 (WHO 2012)
• TB treatment (DOTS)Cost of $100 per patientEffective at 90% (WHO 2012)
• Current DOTS coverage- average of 71%- bottom income quintile: 47%- top income quintile: 95%
04/10/2023
UPF for TB Treatment Over 1 Year for 1 Million Indians
12
TB deaths averted
Poorest 2nd Poorest Middle 2nd Richest Richest
Treat TB-infected with DOTS
DOTS coverage (~ 90%)
DOTS effectiveness
(~ 90%)
TB costs averted for households
Financial protection
benefits
04/10/2023
Benefits over 1 Year with UPF for 90% coverage of TB Treatment (per
million population)
13
Outcome Total Income
Quintile I (Poorest)
Income Quintile II (Poorer)
Income Quintile III (Middle)
Income Quintile IV
(Richer)
Income Quintile V (Richest)
1 TB deaths averted 80 40 25 12 3 0
2Private
expenditures crowded out
$29,000 6,000 6,000 7,000 6,000 4,000
3Money-
metric value of insurance
$9,000 5,000 2,000 1,000 1,000 0
Total cost of public program of $65,000
04/10/2023
Coping Mechanisms: Borrowing
14
• Without UPF, when faced with costly treatment, the poor borrow from peers or sell assets
• 50% of poor households in India borrow money/sell assets at high interest rates (Kruk et al. 2009)
• Assume the poor take a loan over 10 years at annual interest rate of 20% to subsidize TB treatment
04/10/2023
Benefits over 1 Year for 1 Million Indians with UPF for TB Treatment
15
Outcome Total Income
Quintile I (Poorest)
Income Quintile II (Poorer)
Income Quintile III (Middle)
Income Quintile IV
(Richer)
Income Quintile V (Richest)
1 TB deaths averted 150 100 50 0 0 0
2Private
expenditures crowded out
$70,000 0 15,000 25,000 20,000 10,000
3Money-
metric value of insurance
$10,000 0 3,000 4,000 2,000 1,000
Total cost of public program of $130,000
04/10/2023 16
Comparative Analysis – Ethiopia
Stéphane Verguet, Zachary Olson, Joseph Babigumira, Margaret Kruk,Kjell Arne Johansson, Carol Levin,
Rachel Nugent, Clint Pecenka, Mark Shrime,David Watkins, Dean Jamison
04/10/2023
Ethiopia
17
04/10/2023 18
Thank you
Contact Information:Djamison@uw.edu
Recommended